The results of our study corresponded with our long-time observation of immunophenotyping patterns in MS patients, i.e. higher level of CD4+ lymphocytes with a decreased expression of CD45RA molecules and lower proportion of B lymphocytes and NK cells. Here, CD4 is linked to myeloid sarcoma.